{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0012552/OMIM:610755","label":"Multiple endocrine neoplasia, type IV","mondoId":"MONDO:0012552","onsetQualifier":null,"recordKeys":["0eda166169dd1f386e1fe0a4149c8044ffa31bbdab27bdee33c06c15047be75d","125c916e02ceb59fea161869d960150a951d71172e97d44e3b8fd0dc70d3e189","1316e11b228d901236b7395389d8403d179076b4af24423a39cd4e208dc14d91","28f857f26d7cc375957c8b1c0e758bcd6e04c36119698a2fb166719e43e96e17","461eabba3f33c5ebd03de0a9080cf592b530eddc3acd8bd5aa9eb807ca205e93","616040008cb94ab17c1e599aa2743143a6be426c9678998d737d46c11c12ac77","9c83dbbfe634f6a2265f9f0e210fbcd0ad8fdaf92afa2703321c73056d51d8bb","aaca3f203559c33ed5e9e6a0135a5fc04bea25f21a3de2a7b1fe4df0b6e1a0bc","c82aa052171f82fd31cdf03f734254a4a0e9ee13c420a67cddc46cb2194da915","dcd4bca470abe2b48747d957cfef921517b9fb0c2f7074a8174462bf3167c596","f79fdda32ee1295bb750a365987a82e11bdb30356d054e1d3360dbf3b5a51f83"],"recordQualifiers":{},"scopeLabel":"OMIM:610755","sourceIds":["OMIM:610755"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0012552/ORPHA:276152","label":"Multiple endocrine neoplasia type 4","mondoId":"MONDO:0012552","onsetQualifier":null,"recordKeys":["050dae641b4e66d148a9f8e2281029096eb68ede9972cd0cd6deded38ea7ba5b","1f54f511fc2f17da4af5917514341bf2d7f9e0fdc91580f5e2da814f102b8478","2fdc0b4b05f49633cc4e41959d81d6519d60b5fa0d8bd25797305b0b8cfa227c","3593c0d843f36d7623d06ba912c103417eae78fed372da9f71aaa08fb0b29414","36303c0a1d6b5150213a91c265ac1f8a4bad37cb43eed930fcd5d1768d8100e1","54ab929fb1c5666808dd30017c42c58c05720d2eba960840c2f63878634ddf55","60664a0f10188cd643cf465cb98b7a27739983e6b7c7f575dddbcbce73e9e5ec","6c986d1acc94271f7177aebeb7981226258b2540e1b33d1b6aa27d9f92143d34","712f5f15f677a4628c4f5213c71509f3504452adc406a6b4774f2a34bac5d920","76199a28f258c0461e345e127e796d7336ac3df27d80358935d43236e0626dd6","7bd3c3923391952efd4c52c37a3dffcd00e3d1099b411ac974a0bf971826a1cc","7c3a6cd6cc32cd04cc52cbc742a2df3660497e48c989d6fdf9efba88f7d85baa","84e3a2fbec323c74114fb1f074d88a166b48abbf29ff8ae8bed1eb48b99704da","89969117a27bcde4d041cd8d348f055212d8922d5bc40be0a9a4aee0cc4be6d9","928a5f41c3b49514a0d19cd5ce6e722dd38e350192b9205dc9f326b91e955632","92fcb0a992bd22180c4b8476ba6186292d9dc158bba2cf7591353b3b7c4bb3bc","9a2fc1e30e3187f2237a82168907a1dc94ad948ff97794aff5839c6328ded584","9d4eb35d7cc550d8299a1515dcd2cf355066580ce363c3fcdf384421471ba927","9d886bec4599d62299902b6caa2918e85b9be687f1834ffe87e195c7a1aab7a3","9edf7bc9c03a3971d642e471ec92205f833a3f5e67b2bfd481cfa99bf4cc262d","a054c11893f5edfa3d62fc08dc78b78c85df8f282864cb3c5a1b22720f48956d","a4bd471c57e3d03d626091a55f1f29e1c83bffba4a666af6c71e4392cb8d0f2e","a72c2c98b1dfee25f59ef53fe152fdea73883b6a3a7de240af34a315b0051d41","ae8bc42ebc2d57c15b1a3d356ec35a3e03685af5741b5b5d2e8b6a4fa14168a4","b820dc7c2dcbc120179782df2419a83746c77caf16bd3cbc569751804d118aec","beed6acf77e273c5bf465b64a0c10668cac63e1e2f729ceaf4a876cd1253df7f","ce235aa308076fbf3eb5eb0711cbc9737ef621456a5caa658f9b3288e78663f4","d4888e8fe55cae3c1e705ff9dcd533ff9547c1add40bd0823021876819d3d5dc","d85704556fd44aa133f0f46dcba125b71af593653923325cd4a1126d8f59bf73","dd5495aeee92fa6fbe74b22c71caa629c4075686e81fce281bb0a455586585d3","dec4fd9fb69aa09726bc62cfd1ba95a1753808f50afb224e3a2923ed3a98db9a","e2b419a64b986ac8d07386adbed5a7a6e15de2963079a8c692a923fe98aa0eb7","e6caae37d686eda8027d6711bb8b3e00c79d0d0bb29e0fa0df9335d0310410d9","e9812ea717de0ebeea7e6c87af052563ab533e6d544050927989026d928a031c","ed82a87fd474681273e3efdf6d8e81e549c1209fddcd0676f2bdc29a63a582c2","edd44cef0a1b0fdc3a3860afefded109b51f6d52941a9e23f5183056ce4be0cc","f94813fd22f87c05ec45a0e49140c859bb90b7f90858496e8bdf5fd106ce53b1","feadb4c5e05d5851509cebcf6e978643763b183ff556a41fb8cab3e280d90484","ff546788ee94bf3e417fab4ae9a173879ea36817435fc522dd3a0f3279c4b033"],"recordQualifiers":{},"scopeLabel":"ORPHA:276152","sourceIds":["ORPHA:276152"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0012552/OMIM:610755","MONDO:0012552/ORPHA:276152"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":50,"sourceGroups":{"omim":5,"orphanet":39,"published":6}},"features":[{"hpoId":"HP:0012091","label":"Abnormality of pancreas physiology","primary":false},{"hpoId":"HP:0000818","label":"Abnormality of the endocrine system","primary":false},{"hpoId":"HP:0008256","label":"Adrenocortical adenoma","primary":false},{"hpoId":"HP:0010615","label":"Angiofibromas","primary":false},{"hpoId":"HP:0100570","label":"Carcinoid tumor","primary":false},{"hpoId":"HP:0030731","label":"Carcinoma","primary":false},{"hpoId":"HP:0030079","label":"Cervix cancer","primary":false},{"hpoId":"HP:0007449","label":"Confetti-like hypopigmented macules","primary":false},{"hpoId":"HP:0002014","label":"Diarrhea","primary":false},{"hpoId":"HP:0000845","label":"Elevated circulating growth hormone concentration","primary":false},{"hpoId":"HP:0003165","label":"Elevated circulating parathyroid hormone level","primary":false},{"hpoId":"HP:0002574","label":"Episodic abdominal pain","primary":false},{"hpoId":"HP:0010783","label":"Erythema","primary":false},{"hpoId":"HP:0100633","label":"Esophagitis","primary":false},{"hpoId":"HP:0012334","label":"Extrahepatic cholestasis","primary":false},{"hpoId":"HP:0008283","label":"Fasting hyperinsulinemia","primary":false},{"hpoId":"HP:0000872","label":"Hashimoto thyroiditis","primary":false},{"hpoId":"HP:0003072","label":"Hypercalcemia","primary":false},{"hpoId":"HP:0000825","label":"Hyperinsulinemic hypoglycemia","primary":false},{"hpoId":"HP:0000843","label":"Hyperparathyroidism","primary":false},{"hpoId":"HP:0000821","label":"Hypothyroidism","primary":false},{"hpoId":"HP:0003118","label":"Increased circulating cortisol level","primary":false},{"hpoId":"HP:0030688","label":"Increased glucagon level","primary":false},{"hpoId":"HP:0012030","label":"Increased urinary cortisol level","primary":false},{"hpoId":"HP:0012197","label":"Insulinoma","primary":false},{"hpoId":"HP:0100634","label":"Neuroendocrine neoplasm","primary":false},{"hpoId":"HP:0030405","label":"Pancreatic endocrine tumor","primary":false},{"hpoId":"HP:0002897","label":"Parathyroid adenoma","primary":false},{"hpoId":"HP:0006780","label":"Parathyroid carcinoma","primary":false},{"hpoId":"HP:0008208","label":"Parathyroid hyperplasia","primary":false},{"hpoId":"HP:0004398","label":"Peptic ulcer","primary":false},{"hpoId":"HP:0002893","label":"Pituitary adenoma","primary":false},{"hpoId":"HP:0008291","label":"Pituitary corticotropic cell adenoma","primary":false},{"hpoId":"HP:0011760","label":"Pituitary growth hormone cell adenoma","primary":false},{"hpoId":"HP:0011761","label":"Pituitary null cell adenoma","primary":false},{"hpoId":"HP:0006767","label":"Pituitary prolactin cell adenoma","primary":false},{"hpoId":"HP:0008200","label":"Primary hyperparathyroidism","primary":false},{"hpoId":"HP:0030445","label":"Pulmonary carcinoid tumor","primary":false},{"hpoId":"HP:0006772","label":"Renal angiomyolipoma","primary":false},{"hpoId":"HP:0001031","label":"Subcutaneous lipoma","primary":false},{"hpoId":"HP:0010788","label":"Testicular neoplasm","primary":false},{"hpoId":"HP:0100522","label":"Thymoma","primary":false},{"hpoId":"HP:0000854","label":"Thyroid adenoma","primary":false},{"hpoId":"HP:0002044","label":"Zollinger-Ellison syndrome","primary":false}],"ledeHtml":"Multiple endocrine neoplasia is a group of disorders that affect the body&#x27;s network of hormone-producing glands called the endocrine system. Hormones are chemical messengers that travel through the bloodstream and regulate the function of cells and tissues throughout the body. Multiple endocrine neoplasia typically involves tumors (neoplasia) in at least two endocrine glands; tumors can also develop in other organs and tissues. These growths can be noncancerous (benign) or cancerous (malignant). If the tumors become cancerous, the condition can be life-threatening.","mondoId":"MONDO:0017169","records":[{"frequencyKind":"range","key":"050dae641b4e66d148a9f8e2281029096eb68ede9972cd0cd6deded38ea7ba5b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030688","is_excluded":false,"label":"Increased glucagon level","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"0eda166169dd1f386e1fe0a4149c8044ffa31bbdab27bdee33c06c15047be75d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0008200","is_excluded":false,"label":"Primary hyperparathyroidism","onset_id":null,"reference":"PMID:24819502","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"125c916e02ceb59fea161869d960150a951d71172e97d44e3b8fd0dc70d3e189","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002893","is_excluded":false,"label":"Pituitary adenoma","onset_id":null,"reference":"OMIM:610755","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1316e11b228d901236b7395389d8403d179076b4af24423a39cd4e208dc14d91","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0030731","is_excluded":false,"label":"Carcinoma","onset_id":null,"reference":"OMIM:610755","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"1f54f511fc2f17da4af5917514341bf2d7f9e0fdc91580f5e2da814f102b8478","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002897","is_excluded":false,"label":"Parathyroid adenoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"28f857f26d7cc375957c8b1c0e758bcd6e04c36119698a2fb166719e43e96e17","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000821","is_excluded":false,"label":"Hypothyroidism","onset_id":null,"reference":"PMID:24819502","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"2fdc0b4b05f49633cc4e41959d81d6519d60b5fa0d8bd25797305b0b8cfa227c","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002574","is_excluded":false,"label":"Episodic abdominal pain","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3593c0d843f36d7623d06ba912c103417eae78fed372da9f71aaa08fb0b29414","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008256","is_excluded":false,"label":"Adrenocortical adenoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"36303c0a1d6b5150213a91c265ac1f8a4bad37cb43eed930fcd5d1768d8100e1","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0006772","is_excluded":false,"label":"Renal angiomyolipoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"461eabba3f33c5ebd03de0a9080cf592b530eddc3acd8bd5aa9eb807ca205e93","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000843","is_excluded":false,"label":"Hyperparathyroidism","onset_id":null,"reference":"PMID:24819502","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"54ab929fb1c5666808dd30017c42c58c05720d2eba960840c2f63878634ddf55","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002893","is_excluded":false,"label":"Pituitary adenoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"60664a0f10188cd643cf465cb98b7a27739983e6b7c7f575dddbcbce73e9e5ec","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0010615","is_excluded":false,"label":"Angiofibromas","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"616040008cb94ab17c1e599aa2743143a6be426c9678998d737d46c11c12ac77","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"TAS","frequency_raw":"1/1","hpo_id":"HP:0002897","is_excluded":false,"label":"Parathyroid adenoma","onset_id":null,"reference":"PMID:24819502","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"6c986d1acc94271f7177aebeb7981226258b2540e1b33d1b6aa27d9f92143d34","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030079","is_excluded":false,"label":"Cervix cancer","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"712f5f15f677a4628c4f5213c71509f3504452adc406a6b4774f2a34bac5d920","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100634","is_excluded":false,"label":"Neuroendocrine neoplasm","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"76199a28f258c0461e345e127e796d7336ac3df27d80358935d43236e0626dd6","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002014","is_excluded":false,"label":"Diarrhea","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7bd3c3923391952efd4c52c37a3dffcd00e3d1099b411ac974a0bf971826a1cc","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000818","is_excluded":false,"label":"Abnormality of the endocrine system","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7c3a6cd6cc32cd04cc52cbc742a2df3660497e48c989d6fdf9efba88f7d85baa","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003118","is_excluded":false,"label":"Increased circulating cortisol level","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"84e3a2fbec323c74114fb1f074d88a166b48abbf29ff8ae8bed1eb48b99704da","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000825","is_excluded":false,"label":"Hyperinsulinemic hypoglycemia","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"89969117a27bcde4d041cd8d348f055212d8922d5bc40be0a9a4aee0cc4be6d9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003072","is_excluded":false,"label":"Hypercalcemia","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"928a5f41c3b49514a0d19cd5ce6e722dd38e350192b9205dc9f326b91e955632","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000854","is_excluded":false,"label":"Thyroid adenoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"92fcb0a992bd22180c4b8476ba6186292d9dc158bba2cf7591353b3b7c4bb3bc","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002044","is_excluded":false,"label":"Zollinger-Ellison syndrome","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9a2fc1e30e3187f2237a82168907a1dc94ad948ff97794aff5839c6328ded584","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0006767","is_excluded":false,"label":"Pituitary prolactin cell adenoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"9c83dbbfe634f6a2265f9f0e210fbcd0ad8fdaf92afa2703321c73056d51d8bb","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0006772","is_excluded":false,"label":"Renal angiomyolipoma","onset_id":null,"reference":"OMIM:610755","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9d4eb35d7cc550d8299a1515dcd2cf355066580ce363c3fcdf384421471ba927","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010788","is_excluded":false,"label":"Testicular neoplasm","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9d886bec4599d62299902b6caa2918e85b9be687f1834ffe87e195c7a1aab7a3","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030445","is_excluded":false,"label":"Pulmonary carcinoid tumor","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9edf7bc9c03a3971d642e471ec92205f833a3f5e67b2bfd481cfa99bf4cc262d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000843","is_excluded":false,"label":"Hyperparathyroidism","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a054c11893f5edfa3d62fc08dc78b78c85df8f282864cb3c5a1b22720f48956d","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012334","is_excluded":false,"label":"Extrahepatic cholestasis","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a4bd471c57e3d03d626091a55f1f29e1c83bffba4a666af6c71e4392cb8d0f2e","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007449","is_excluded":false,"label":"Confetti-like hypopigmented macules","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a72c2c98b1dfee25f59ef53fe152fdea73883b6a3a7de240af34a315b0051d41","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0006780","is_excluded":false,"label":"Parathyroid carcinoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"aaca3f203559c33ed5e9e6a0135a5fc04bea25f21a3de2a7b1fe4df0b6e1a0bc","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0030405","is_excluded":false,"label":"Pancreatic endocrine tumor","onset_id":null,"reference":"PMID:24819502","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ae8bc42ebc2d57c15b1a3d356ec35a3e03685af5741b5b5d2e8b6a4fa14168a4","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100522","is_excluded":false,"label":"Thymoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b820dc7c2dcbc120179782df2419a83746c77caf16bd3cbc569751804d118aec","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001031","is_excluded":false,"label":"Subcutaneous lipoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"beed6acf77e273c5bf465b64a0c10668cac63e1e2f729ceaf4a876cd1253df7f","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008283","is_excluded":false,"label":"Fasting hyperinsulinemia","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"c82aa052171f82fd31cdf03f734254a4a0e9ee13c420a67cddc46cb2194da915","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000872","is_excluded":false,"label":"Hashimoto thyroiditis","onset_id":null,"reference":"PMID:24819502","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ce235aa308076fbf3eb5eb0711cbc9737ef621456a5caa658f9b3288e78663f4","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012197","is_excluded":false,"label":"Insulinoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d4888e8fe55cae3c1e705ff9dcd533ff9547c1add40bd0823021876819d3d5dc","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004398","is_excluded":false,"label":"Peptic ulcer","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d85704556fd44aa133f0f46dcba125b71af593653923325cd4a1126d8f59bf73","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012091","is_excluded":false,"label":"Abnormality of pancreas physiology","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"dcd4bca470abe2b48747d957cfef921517b9fb0c2f7074a8174462bf3167c596","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000845","is_excluded":false,"label":"Elevated circulating growth hormone concentration","onset_id":null,"reference":"OMIM:610755","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"dd5495aeee92fa6fbe74b22c71caa629c4075686e81fce281bb0a455586585d3","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100570","is_excluded":false,"label":"Carcinoid tumor","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dec4fd9fb69aa09726bc62cfd1ba95a1753808f50afb224e3a2923ed3a98db9a","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008291","is_excluded":false,"label":"Pituitary corticotropic cell adenoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e2b419a64b986ac8d07386adbed5a7a6e15de2963079a8c692a923fe98aa0eb7","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100633","is_excluded":false,"label":"Esophagitis","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e6caae37d686eda8027d6711bb8b3e00c79d0d0bb29e0fa0df9335d0310410d9","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003165","is_excluded":false,"label":"Elevated circulating parathyroid hormone level","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e9812ea717de0ebeea7e6c87af052563ab533e6d544050927989026d928a031c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008208","is_excluded":false,"label":"Parathyroid hyperplasia","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ed82a87fd474681273e3efdf6d8e81e549c1209fddcd0676f2bdc29a63a582c2","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010783","is_excluded":false,"label":"Erythema","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"edd44cef0a1b0fdc3a3860afefded109b51f6d52941a9e23f5183056ce4be0cc","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012030","is_excluded":false,"label":"Increased urinary cortisol level","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f79fdda32ee1295bb750a365987a82e11bdb30356d054e1d3360dbf3b5a51f83","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610755","disease_name":"Multiple endocrine neoplasia, type IV","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0100570","is_excluded":false,"label":"Carcinoid tumor","onset_id":null,"reference":"OMIM:610755","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f94813fd22f87c05ec45a0e49140c859bb90b7f90858496e8bdf5fd106ce53b1","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000845","is_excluded":false,"label":"Elevated circulating growth hormone concentration","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"feadb4c5e05d5851509cebcf6e978643763b183ff556a41fb8cab3e280d90484","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011761","is_excluded":false,"label":"Pituitary null cell adenoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ff546788ee94bf3e417fab4ae9a173879ea36817435fc522dd3a0f3279c4b033","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276152","disease_name":"Multiple endocrine neoplasia type 4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011760","is_excluded":false,"label":"Pituitary growth hormone cell adenoma","onset_id":null,"reference":"ORPHA:276152","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<ul><li><a href=\"https://medlineplus.gov/genetics/condition/multiple-endocrine-neoplasia\">Multiple endocrine neoplasia</a></li></ul>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p class=\"note\">Source describes multiple endocrine neoplasia.</p><p>Mutations in the MEN1, RET, and CDKN1B genes can cause multiple endocrine neoplasia.</p><p>Mutations in the MEN1 gene cause multiple endocrine neoplasia type 1. This gene provides instructions for producing a protein called menin. Menin acts as a tumor suppressor, which means it normally keeps cells from growing and dividing too rapidly or in an uncontrolled way. Although the exact function of menin is unknown, it is likely involved in cell functions such as copying and repairing DNA and regulating the activity of other genes. When mutations inactivate both copies of the MEN1 gene, menin is no longer available to control cell growth and division. The loss of functional menin allows cells to divide too frequently, leading to the formation of tumors characteristic of multiple endocrine neoplasia type 1. It is unclear why these tumors preferentially affect endocrine tissues.</p><p>Mutations in the RET gene cause multiple endocrine neoplasia type 2. This gene provides instructions for producing a protein that is involved in signaling within cells. The RET protein triggers chemical reactions that instruct cells to respond to their environment, for example by dividing or maturing. Mutations in the RET gene overactivate the protein&#x27;s signaling function, which can trigger cell growth and division in the absence of signals from outside the cell. This unchecked cell division can lead to the formation of tumors in endocrine glands and other tissues.</p><p>Mutations in the CDKN1B gene cause multiple endocrine neoplasia type 4. This gene provides instructions for making a protein called p27. Like the menin protein, p27 is a tumor suppressor that helps control the growth and division of cells. Mutations in the CDKN1B gene reduce the amount of functional p27, which allows cells to grow and divide unchecked. This unregulated cell division can lead to the development of tumors in endocrine glands and other tissues.</p><p class=\"section-source\"><a href=\"https://medlineplus.gov/genetics/condition/multiple-endocrine-neoplasia/#causes\">MedlinePlus Genetics: Causes</a></p>","key":"forms","title":"What causes multiple endocrine neoplasia?"},{"bodyHtml":"<p>The major forms of multiple endocrine neoplasia are called type 1, type 2, and type 4. These types are distinguished by the genes involved, the types of hormones made, and the characteristic signs and symptoms.</p><p>Many different types of tumors are associated with multiple endocrine neoplasia. Type 1 frequently involves tumors of the parathyroid glands, the pituitary gland, and the pancreas. Tumors in these glands can lead to the overproduction of hormones. The most common sign of multiple endocrine neoplasia type 1 is overactivity of the parathyroid glands (hyperparathyroidism). Hyperparathyroidism disrupts the normal balance of calcium in the blood, which can lead to kidney stones, thinning of bones, nausea and vomiting, high blood pressure (hypertension), weakness, and fatigue.</p><p>The most common sign of multiple endocrine neoplasia type 2 is a form of thyroid cancer called medullary thyroid carcinoma. Some people with this disorder also develop a pheochromocytoma, which is an adrenal gland tumor that can cause dangerously high blood pressure. Multiple endocrine neoplasia type 2 is divided into three subtypes: type 2A, type 2B (formerly called type 3), and familial medullary thyroid carcinoma (FMTC). These subtypes differ in their characteristic signs and symptoms and risk of specific tumors; for example, hyperparathyroidism occurs only in type 2A, and medullary thyroid carcinoma is the only feature of FMTC. The signs and symptoms of multiple endocrine neoplasia type 2 are relatively consistent within any one family.</p><p>Multiple endocrine neoplasia type 4 appears to have signs and symptoms similar to those of type 1, although it is caused by mutations in a different gene. Hyperparathyroidism is the most common feature, followed by tumors of the pituitary gland, additional endocrine glands, and other organs.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/multiple-endocrine-neoplasia\">MedlinePlus Genetics</a></p><p class=\"note\">Source describes multiple endocrine neoplasia.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"multiple-endocrine-neoplasia","sourceDocuments":[{"name":"Multiple endocrine neoplasia","reviewed":"2013-08","sections":{"causes":{"fetchedAt":"2026-10-20T20:23:32.504904+00:00","label":"Causes","pageSha256":"7529ffac35ef9c4a64af91e29e5f1a862034e024ac94d7135964baca082ed64e","sourceUrl":"https://medlineplus.gov/genetics/condition/multiple-endocrine-neoplasia/#causes","status":"available"}},"source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/multiple-endocrine-neoplasia"}],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause explanations are from MedlinePlus Genetics. Feature values below retain their original sources and patient groups.","title":"multiple endocrine neoplasia"},"schemaVersion":1}